← Insider buys

Andrew J. Mills bought MDLN once, on Dec 18, 2025

Director at Medline Inc.

SEC CIK 0001460212 · Filings on SEC.gov ↗

$75.0MBought
$0Sold
Dec 22Last buy

Andrew J. Mills's record

3 months after each buy, from the first price a copier could get.

1 buy has 3 months of prices so far. A record shows here at 3.

Every filing

1 filing since Dec 2025, newest first

About Andrew J. Mills

Andrew J. Mills is a prominent executive in the healthcare industry, serving as Vice Chairman at Medline Industries LP since 2023 and Director at Medline Inc. (MDLN), where he recently engaged in significant insider trading, including a purchase of 2,586,206 shares on December 18, 2025, at $29 per share, totaling approximately $75 million, and owning about 2,616,861 shares as of early 2026.( He holds additional roles such as Director at HIDA Educational Foundation since 2010, Director at Medline Operations Ltd. since 2017, Co-Managing Director and CEO at Medline Assembly Slovakia sro since 2014, and Trustee at Adler Planetarium & Astronomy Museum; he is also the founder of Vivo Foundation in 2021.(

Mills previously served as a Trustee at Endeavor Health Clinical Operations.( His educational background includes an MBA from Northwestern University and an undergraduate degree from Tulane University.( With a net worth estimated at least at $115 million tied to his Medline holdings as of January 2026, Mills plays a key leadership role in Medline, a company founded in 1910 by A.J. Mills, specializing in manufacturing and distributing healthcare supplies.(

Written by Perplexity from public sources.

Filings come from SEC EDGAR. Not investment advice.